KUALA LUMPUR: Malaysian Genomics Resource Centre Bhd
(MGRC) is not aware of any corporate development or other reasons for the sharp fall in its share price recently.
The genomics firm, which provides healthcare services such as genetic screening and cancer-related immunotherapy, said its board has made due enquiry on the matter with the company’s directors, major shareholders and such other relevant persons.
Already a subscriber? Log in.
Unlock 30% Savings on Ad-Free Access Now!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
